Dynavax Technologies
Corporation DVAX today announced the appointment of
Christine Larson to the position of Vice President and Chief
Financial Officer, a newly created position. Ms. Larson brings nearly
25 years of experience as a financial professional to the role,
including a background in corporate finance and investment banking.
Ms. Larson joins Dynavax from PDL Biopharma, Inc. (PDL), where she
was responsible for leading financial and strategic planning,
accounting, and treasury and investor relations for the public
company, which earned annual revenues of $350 million. During her
tenure at PDL, Ms. Larson designed and implemented a complex
recapitalization strategy, including debt issuance and restructuring,
as well as led the development of new accounting infrastructure
following the company's spin-out of biotechnology assets to Facet
Biotech Corporation in 2008.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsManagement
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in